C. Vermylen
- Hematology top 5%
- Epidemiology
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Hepatology top 5%
- Co-authors
- H. ClaeysMarc VerstraeteM VerstraeteAlfons BilliauMarc De LeyJ. VermylenJ VandenbrouckeA Amery
- Topics
- Hepatitis B Virus Studies (7 papers)Hepatitis C virus research (7 papers)Hemophilia Treatment and Research (6 papers)
- Partner nations
- BelgiumSwitzerlandGermany
In The Last Decade
C. Vermylen
43 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 92
- Hematology 339
- Epidemiology 248
- Pulmonary and Respiratory Medicine 227
- Immunology 203
- Hepatology 202
Countries citing papers authored by C. Vermylen
This map shows the geographic impact of C. Vermylen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Vermylen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Vermylen more than expected).
Fields of papers citing papers by C. Vermylen
This network shows the impact of papers produced by C. Vermylen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Vermylen. The network helps show where C. Vermylen may publish in the future.
Co-authorship network of co-authors of C. Vermylen
This figure shows the co-authorship network connecting the top 25 collaborators of C. Vermylen. A scholar is included among the top collaborators of C. Vermylen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Vermylen. C. Vermylen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 39 | |
| 2 | 10 | |
| 3 | Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management. | 16 |
| 4 | 3 | |
| 5 | 87 | |
| 6 | 2 | |
| 7 | 110 | |
| 8 | 16 | |
| 9 | 25 | |
| 10 | 17 | |
| 11 | 3 | |
| 12 | 29 | |
| 13 | 8 | |
| 14 | 2 | |
| 15 | 105 | |
| 16 | 239 | |
| 17 | 28 | |
| 18 | 12 | |
| 19 | 24 | |
| 20 | [Experimental studies on some problems of blood coagulation with reference to extracorporeal circulation]. | 2 |
About C. Vermylen
C. Vermylen is a scholar working on Transplantation, Hematology and Hepatology, having authored 45 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and Hemophilia Treatment and Research (6 papers). The work is most often cited by research in Hematology (339 citations), Hepatology (202 citations) and Internal Medicine (51 citations). C. Vermylen has collaborated with scholars based in Belgium, Switzerland and Germany. Frequent co-authors include H. Claeys, Marc Verstraete, M Verstraete, Alfons Billiau, Marc De Ley, J. Vermylen, J Vandenbroucke, A Amery, Piet De Somer and J. Vermylen. Their work appears in journals such as The Lancet, Neurology and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.